FindTrial
Sign In

management of antithrombotic therapy for nonvariceal upper gastrointestinal bleeding

management of antithrombotic therapy for nonvariceal upper gastrointestinal bleeding - Antithrombotic therapy and nonvariceal upper gastrointestinal bleeding

Status
Unknown
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000023467
Enrollment
100
Registered
2016-08-03
Start date
2016-08-03
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

nonvariceal upper gastrointestinal bleeding

Interventions

None listed

Sponsors

shonan kamakura general hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)Patient who underwent endoscopy for acute upper gastrointestinal bleeding with proved source of blood losses in upper gastrointestinal tract 2)Patient who was taking antithrombotic medication 3)Patient who was explained about the study, understood it, and gave the consent form

Exclusion criteria

Exclusion criteria: Patient with 1.pregnant or lactating women and women who may be pregnant 2. allrgic to proton pump inhibitor 3.an uncontrollable heart trouble (myocardial infarction, heart failure, or arrhythmia) 4.renal disease, Cre >2mg/dl 5.liver disease, ALT levels that were more than 2.5 times the upper limit of the normal range

Design outcomes

Primary

MeasureTime frame
Rebleeding rate after resumption of antithrombotic treatment—

Countries

Japan

Contacts

Public ContactIchida chikamasa

shonan kamakura general hospital department of gastroenterology

ichikamasa@yahoo.co.jp0467-46-1717

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026